Based on the Vivani Medical Inc. stock forecast from 0 analysts, the average analyst target price for Vivani Medical Inc. is not available over the next 12 months. Vivani Medical Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Vivani Medical Inc. is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Vivani Medical Inc.’s stock price was USD 1.14. Vivani Medical Inc.’s stock price has changed by -2.56% over the past week, -5.79% over the past month and +11.76% over the last year.
No recent analyst target price found for Vivani Medical Inc.
No recent average analyst rating found for Vivani Medical Inc.
Company Overview Vivani Medical Inc.
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California. Read Less
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates ...Read More
Frequently Asked Questions About Vivani Medical Inc. (VANI) Stock
Stock Target Advisor's fundamental analysis for Vivani Medical Inc.'s stock is Slightly Bearish.
Unfortunately we do not have enough data on VANI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on VANI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on VANI's stock to indicate if its overvalued.
The last closing price of VANI's stock was USD 1.14.
The most recent market capitalization for VANI is USD 0.07B.
Unfortunately we do not have enough analyst data on VANI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Vivani Medical Inc.'s stock.
As per our most recent records Vivani Medical Inc. has 36 Employees.
Vivani Medical Inc.'s registered address is 1350 South Loop Road, Alameda, CA, United States, 94502.
You can get more information about it from Vivani Medical Inc.'s website at https://www.vivani.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Vivani Medical Inc. (VANI) Stock
Stock Target Advisor's fundamental analysis for Vivani Medical Inc.'s stock is Slightly Bearish.
Unfortunately we do not have enough data on VANI's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on VANI's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on VANI's stock to indicate if its overvalued.
The last closing price of VANI's stock was USD 1.14.
The most recent market capitalization for VANI is USD 0.07B.
Unfortunately we do not have enough analyst data on VANI's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Vivani Medical Inc.'s stock.
As per our most recent records Vivani Medical Inc. has 36 Employees.
Vivani Medical Inc.'s registered address is 1350 South Loop Road, Alameda, CA, United States, 94502.
You can get more information about it from Vivani Medical Inc.'s website at https://www.vivani.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VANI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
